David M. Neskey, M.D., MSCR, FACS is an assistant professor in the Department of Otolaryngology in the division of Head and Neck Surgical Oncology. Originally from Massachusetts, he received his medical degree from Albany Medical College with a distinction in research in 2006 followed by a residency in Otolaryngology Head and Neck Surgery at the University of Miami. He then completed a fellowship in head and neck surgical oncology at MD Anderson Cancer Center in Houston. This training experience was comprised of two years dedicated to basic science research followed by a year committed to the management of patients with head and neck cancer.
Dr Neskey's clinical focus is on the care of patients with benign and malignant neoplasias of the head and neck including oral cavity, oropharyngeal, laryngeal lesions, and skullbase, advanced melanoma and nonmelanoma skin cancers, and lesions of the salivary glands, thyroid and parathyroids. His specific interests are squamous cell carcinoma of the oral cavity and oropharynx along with advanced skin cancer and skull base tumors. He currently sees patients in Hollings Cancer Center.
Dr. Neskey has published over 30 peer reviewed articles and book chapters focused on the molecular pathways and genomic alterations associated with head and neck squamous cell carcinoma. Based on this work, he is currently funded through the National Institute of Health to study the mechanisms of invasion and metastases in head and neck cancer. In addition to his lab based studies, Dr. Neskey is the principle investigator in several ongoing trials, including an investigator-initiated trial investigating immunotherapy, a presurgical treatment for patients with oral cavity cancer. He is board certified by the American Board of Otolaryngology and is a member of the American Head and Neck Society, American Academy of Clinical Research, and a Fellow of the American College of Surgeons.